Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients

Human Immunology

Volumn 60, Issue 5, 1999, Pages 430-434

  Borelli, Sueli D ^a   Ferreira, Euripedes ^b   Oliveira, Aparecido M ^b   Krishnaswamy, Shalini ^c   Hiraki, Debra D ^c   Grumet, F Carl ^c  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Stanford California and Cofounder   (United States)

Author keywords

ELISA; Renal transplant; Soluble HLA; Soluble HLA A2 and HLA B7; Typing

Indexed keywords

HLA ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; URETER OBSTRUCTION;

BIOLOGICAL MARKERS; CADAVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; TIME FACTORS;

EID: 0032719103     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00012-9     Document Type: Article

References (20)

1. Van Rood JJ, van Leeuwen A, van Santen MCT: Anti HL-A2 inhibitor in normal human serum. Nature 226: 366, 1970.
2. Charlton RK, Zmijewski CM: Soluble HL-A7 antigen: localization in the β-lipoprotein fraction of human serum. Science 170:636, 1970.
3. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu RM, Grosse-Wilde H: Summary report from the First International Workshop on soluble HLA antigens, Paris, August 1992. Tissue Antigens 42: 45, 1993.
4. Grumet CF, Buelow R, Grosse-wild H, Kubens B, Garavoy M, Pouletty P: Report of the Second International Soluble HLA (sHLA) Workshop. Hum Immunol 40:153, 1994.
5. Alvarez-Cermeno JC, Casado C, Villar LM: Soluble class I antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol. Scand 82:14, 1990.
6. Alvarez-Cermeno JC, Echevarria JM, Villar LM, Lazaro I, Bootello A, Gonzales-Porque P: Soluble class I antigens in serum and CSF of patient with varicella-zoster virus meningitis. J Neurol Neurosurg 52:1194, 1989.
7. Ferreira A, Villar LM, Alvarez-Cermeno JC: Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients. Clin Chim Acta 174:207, 1988.
8. Westhoff U, Doxiadis I, Beelen DW, Schaefer UW, Grosse-Wild H: Soluble class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation 48:891, 1989.
9. Tilg H, Westhoff U, Vogel W: Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 14:417, 1992.
10. De Vito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ: Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40:191, 1994.
11. Tsujisaki M, Sakaguchi K, Igarashi M, Richiardi P, Perosa F, Ferrone S: Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1. Transplantation 45:632, 1988.
12. Ways JP, Rothbard JB, Parham P: Amino acid residues 56 to 69 of HLA-A2 specificy na antigenic determinant shared by HLA-A2 and HLA-B17. J Immunol 32:125, 1991.
13. De Vito LD, Mason B, Schneck JP, Margulies DH, Sollinger HW, Burlingham WJ: Immunochemical analysis of a recombinant genetically engineered secreted HLA-A2/Q10b fusion protein. Hum Immunol 32:125, 1991.
14. Ellis SA, Taylor C, McMichael A: Recognition of HLA-B27 and related antigen by monoclonal antibody. Hum Immunol 5(1):49, 1982.
15. Hiraki DD, See-Tho K, Filvaroff E, Krisnaswamy S, Bello W, Taidi-Laskowski B, Grumet FC: Bioengineered soluble HLA-B7, genesis, characterization, and occurence of dimerization. Hum Immunol 40:235, 1994.
16. Zavazava N, Leimenstoll G, Mueller-Ruchholtz W: Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor. J Clin Lab Anal 4:426, 1990.
17. Zavazava N, Bottcher H, Mueller-Ruchholtz W: Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 42:20, 1993.
18. Davies HFFS, Pollard SG, Calne RY: Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47:524, 1989.
19. Pollard SG, Davies HFFS, Calne RY: Perioperative appearance of serum class I antigen during liver transplantation Transplantation 49(3):659, 1990.
20. Tilg H, Westhoff U, Vogel W, Aulitzky WE, Herold M, Margreiter R, Huber C, Grosse-Wild H: Soluble HLA class I serum concentrations increase with transplantrelated complications after liver transplantation. J Hepatol 14:417, 1992.